Cargando…

P04 Urinary tract infections in HSCT: how big is the problem?

OBJECTIVES: Urinary tract infections (UTIs) in HSCT recipients are understudied. We aimed to describe the incidence, clinical and laboratory findings of patients with UTIs during HSCT. METHODS: This was a retrospective analysis of all patients admitted for HSCT between 1 January 2020 and 31 December...

Descripción completa

Detalles Bibliográficos
Autores principales: Baltas, Ioannis, Kavallieros, Konstantinos, Konstantinou, Ioannis, Gibani, Malick M, Davies, Frances, Pavlu, Jiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395437/
http://dx.doi.org/10.1093/jacamr/dlad077.008
_version_ 1785083576314757120
author Baltas, Ioannis
Kavallieros, Konstantinos
Konstantinou, Ioannis
Gibani, Malick M
Davies, Frances
Pavlu, Jiri
author_facet Baltas, Ioannis
Kavallieros, Konstantinos
Konstantinou, Ioannis
Gibani, Malick M
Davies, Frances
Pavlu, Jiri
author_sort Baltas, Ioannis
collection PubMed
description OBJECTIVES: Urinary tract infections (UTIs) in HSCT recipients are understudied. We aimed to describe the incidence, clinical and laboratory findings of patients with UTIs during HSCT. METHODS: This was a retrospective analysis of all patients admitted for HSCT between 1 January 2020 and 31 December 2022 in a large London tertiary centre. Patient-level data were collected from the electronic medical record. RESULTS: There was a total of 400 admissions for HSCT during the study period, 56.25% (227/400) for autografts and 43.25% (173/400) for allografts. Median age was 55 years (IQR 43–62) and 59% of patients were male. A total of 588 infection episodes were recorded (mean 1.43 episodes per patient, 95% CI 1.39–1.56). Almost all patients (96.75%, 387/400) developed at least one infection episode during their inpatient stay for HSCT. The most common sources of infection were neutropenic fever (56.1%, 330/588) and non-neutropenic fever (17%, 100/588), followed by central line-associated bloodstream infections (10.2%, 60/588) and hospital- or ventilator-associated pneumonias (7%, 41/588). UTIs accounted for only 2% (12/588) of the total infection episodes. Only two UTIs (16.7%, 2/12) were associated with bacteraemia. A total of 1307 urine cultures were sent for all patients (3.23 per patient) and 93.5% of all patients had at least one urine culture. Growth of a specific pathogen was observed in 50/1307 cultures (3.8% positivity rate). The most common isolates included Escherichia coli (50%, 25/50) and Enterococcus spp. (22%, 11/50). The most common clinical syndrome for patients with positive cultures was neutropenic fever 40%, 20/50), followed by UTI (22%, 11/50) and non-neutropenic fever (6%, 3/50). 32% of positive samples (16/50) were considered to represent colonization. Pyuria was uncommon (8%, 4/50), including in patients with UTIs (18.2%, 2/11), as was haematuria (10%, 5/50 for all patients, 9.1%, 1/11 for patients with UTI). CONCLUSIONS: UTIs account for a small proportion of infections in HSCT recipients during their inpatient stay. Urine culture results are challenging to interpret, as they are often associated with undifferentiated fever syndromes or represent colonization. Urine microscopy results are unreliable in HSCT patients and should not be used to rule in or rule out UTI.
format Online
Article
Text
id pubmed-10395437
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103954372023-08-03 P04 Urinary tract infections in HSCT: how big is the problem? Baltas, Ioannis Kavallieros, Konstantinos Konstantinou, Ioannis Gibani, Malick M Davies, Frances Pavlu, Jiri JAC Antimicrob Resist Abstracts OBJECTIVES: Urinary tract infections (UTIs) in HSCT recipients are understudied. We aimed to describe the incidence, clinical and laboratory findings of patients with UTIs during HSCT. METHODS: This was a retrospective analysis of all patients admitted for HSCT between 1 January 2020 and 31 December 2022 in a large London tertiary centre. Patient-level data were collected from the electronic medical record. RESULTS: There was a total of 400 admissions for HSCT during the study period, 56.25% (227/400) for autografts and 43.25% (173/400) for allografts. Median age was 55 years (IQR 43–62) and 59% of patients were male. A total of 588 infection episodes were recorded (mean 1.43 episodes per patient, 95% CI 1.39–1.56). Almost all patients (96.75%, 387/400) developed at least one infection episode during their inpatient stay for HSCT. The most common sources of infection were neutropenic fever (56.1%, 330/588) and non-neutropenic fever (17%, 100/588), followed by central line-associated bloodstream infections (10.2%, 60/588) and hospital- or ventilator-associated pneumonias (7%, 41/588). UTIs accounted for only 2% (12/588) of the total infection episodes. Only two UTIs (16.7%, 2/12) were associated with bacteraemia. A total of 1307 urine cultures were sent for all patients (3.23 per patient) and 93.5% of all patients had at least one urine culture. Growth of a specific pathogen was observed in 50/1307 cultures (3.8% positivity rate). The most common isolates included Escherichia coli (50%, 25/50) and Enterococcus spp. (22%, 11/50). The most common clinical syndrome for patients with positive cultures was neutropenic fever 40%, 20/50), followed by UTI (22%, 11/50) and non-neutropenic fever (6%, 3/50). 32% of positive samples (16/50) were considered to represent colonization. Pyuria was uncommon (8%, 4/50), including in patients with UTIs (18.2%, 2/11), as was haematuria (10%, 5/50 for all patients, 9.1%, 1/11 for patients with UTI). CONCLUSIONS: UTIs account for a small proportion of infections in HSCT recipients during their inpatient stay. Urine culture results are challenging to interpret, as they are often associated with undifferentiated fever syndromes or represent colonization. Urine microscopy results are unreliable in HSCT patients and should not be used to rule in or rule out UTI. Oxford University Press 2023-08-02 /pmc/articles/PMC10395437/ http://dx.doi.org/10.1093/jacamr/dlad077.008 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Baltas, Ioannis
Kavallieros, Konstantinos
Konstantinou, Ioannis
Gibani, Malick M
Davies, Frances
Pavlu, Jiri
P04 Urinary tract infections in HSCT: how big is the problem?
title P04 Urinary tract infections in HSCT: how big is the problem?
title_full P04 Urinary tract infections in HSCT: how big is the problem?
title_fullStr P04 Urinary tract infections in HSCT: how big is the problem?
title_full_unstemmed P04 Urinary tract infections in HSCT: how big is the problem?
title_short P04 Urinary tract infections in HSCT: how big is the problem?
title_sort p04 urinary tract infections in hsct: how big is the problem?
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395437/
http://dx.doi.org/10.1093/jacamr/dlad077.008
work_keys_str_mv AT baltasioannis p04urinarytractinfectionsinhscthowbigistheproblem
AT kavallieroskonstantinos p04urinarytractinfectionsinhscthowbigistheproblem
AT konstantinouioannis p04urinarytractinfectionsinhscthowbigistheproblem
AT gibanimalickm p04urinarytractinfectionsinhscthowbigistheproblem
AT daviesfrances p04urinarytractinfectionsinhscthowbigistheproblem
AT pavlujiri p04urinarytractinfectionsinhscthowbigistheproblem